CLIENTES - ACCESO PRIVADO    Suscribirse a nuestras novedades (RSS)        
 
BÚSQUEDA:        Buscar
Libros nacionales y extranjeros para bibliotecas,
 
 
Búsqueda avanzada
Libros nacionales y extranjeros para bibliotecas, escuelas, universidades, librerías
     
         
  Arte
Astronomía
Botánica
Ciencia y conocimiento
Ciencias aplicadas / tecnología
Ciencias biológicas
Ciencias sociales
Economía
Filosofía
Física
Generalidades
Geografía
Geología
Historia
Infantil / juvenil
Informática
Ingeniería
Lingüística / filología
Literatura
Matemáticas
Material complementario
Medicina
Ocio
Paleontología / fósiles
Química
Religión y teología
Zoología
   
   
 
   
Los Andes Libros s.l. + 34 935 00 39 13
C/ Andalusia, 3 Local 5 - 08014 Barcelona
 
Downstream Industrial Biotechnology: Recovery and Purification
Michael C. Flickinger (Editor)
Downstream Industrial Biotechnology: Recovery and Purification
ean9781118131244
temáticaBIOTECNOLOGÍA
año Publicación2013
idiomaINGLÉS
editorialWILEY
formatoCARTONÉ


205,70 €


   PEDIR
 
NOVEDAD
 
Últimas novedades
biotecnología
An affordable, easily accessible desk reference on biomanufacturing, focused on downstream recovery and purification

Advances in the fundamental knowledge surrounding biotechnology, novel materials, and advanced engineering approaches continue to be translated into bioprocesses that bring new products to market at a significantly faster pace than most other industries. Industrial scale biotechnology and new manufacturing methods are revolutionizing medicine, environmental monitoring and remediation, consumer products, food production, agriculture, and forestry, and continue to be a major area of research.

The downstream stage in industrial biotechnology refers to recovery, isolation, and purification of the microbial products from cell debris, processing medium and contaminating biomolecules from the upstream process into a finished product such as biopharmaceuticals and vaccines.

Downstream process design has the greatest impact on overall biomanufacturing cost because not only does the biochemistry of different products ( e.g., peptides, proteins, hormones, antibiotics, and complex antigens) dictate different methods for the isolation and purification of these products, but contaminating byproducts can also reduce overall process yield, and may have serious consequences on clinical safety and efficacy. Therefore downstream separation scientists and engineers are continually seeking to eliminate, or combine, unit operations to minimize the number of process steps in order to maximize product recovery at a specified concentration and purity.

Finançat per UE